ShareValue scores for ARVEE.NSE: Valuation 17, Quality 47, Growth 28, Health 54.

ARVEE.NSE
NSE

Arvee Laboratories (India) Limited

₹155.70(+0.41%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-8% to 8%
Valuation
17
Overvalued
Price vs Value
Quality
47
Moderate
Business Strength
Growth
28
Weak
Revenue & Earnings
Health
54
Moderate
Financial Stability
Momentum
64
Bullish
Price Trend

Company Details

About

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also provides drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4"amino pyridine, and 2"chloro"5"nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026